According to ACADIA Pharmaceuticals's latest financial reports the company's current revenue (TTM) is $0.72 B. In 2022 the company made a revenue of $0.51 B an increase over the years 2021 revenue that were of $0.48 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.72 B | 40.45% |
2022 | $0.51 B | 6.83% |
2021 | $0.48 B | 9.6% |
2020 | $0.44 B | 30.28% |
2019 | $0.33 B | 51.5% |
2018 | $0.22 B | 79.19% |
2017 | $0.12 B | 620.68% |
2016 | $17.33 M | 28311.48% |
2015 | $0.06 M | -49.59% |
2014 | $0.12 M | -89.43% |
2013 | $1.14 M | -76.67% |
2012 | $4.9 M | 137.4% |
2011 | $2.06 M | -95.09% |
2010 | $42.13 M | 558.57% |
2009 | $6.39 M | 302.39% |
2008 | $1.59 M | -78.95% |
2007 | $7.55 M | -7.12% |
2006 | $8.13 M | -25.76% |
2005 | $10.95 M | 137.96% |
2004 | $4.6 M | -41.12% |
2003 | $7.82 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 12,705.24% | ๐บ๐ธ USA |
Pfizer PFE | $58.49 B | 7,952.59% | ๐บ๐ธ USA |
Eli Lilly LLY | $34.12 B | 4,597.46% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $45.53 B | 6,168.13% | ๐บ๐ธ USA |
Vanda Pharmaceuticals VNDA | $0.19 B | -73.48% | ๐บ๐ธ USA |
Adamas Pharmaceuticals
ADMS | $88.18 M | -87.86% | ๐บ๐ธ USA |